Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.
Solid Therapeutics's investors include BioInnovation Institute.
Solid Therapeutics is headquartered in Copenhagen, Denmark.
Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.
Solid Therapeutics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Solid Therapeutics — Funding & Investors." VCBacked, September 5, 2023, https://www.vcbacked.co/company/solid-therapeutics. Accessed October 1, 2026.
VCBacked. (2023). Solid Therapeutics — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/solid-therapeutics
{{cite web |title=Solid Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/solid-therapeutics |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated